OncoMed stock doubles after cancer drug deal with Celgene
(Reuters) - Shares of OncoMed Pharmaceuticals Inc more than doubled on Tuesday after the biotechnology company said Celgene Corp would help it develop...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/8uCre0FJb5I/story01.htm
No comments:
Post a Comment